Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 5th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL MYERS SQUIBB CO | $94.60B | $48.03B | $12.94B | $6.04B | $2.97 | 1.26% | 4.05% | N/A | N/A | |||
| LLY | ELI LILLY & CO | $875.25B | $59.42B | $24.40B | $18.41B | $20.49 | 45.41% | 20.68% | 120.56% | 27.21% | |||
| GSK | GSK PLC | $94.17B | $42.89B | $10.28B | $7.33B | $3.61 | 5.51% | -0.34% | 125.18% | -2.46% | |||
| AMRN | AMARIN CORP PLC | $318.34M | $226.73M | -$80.28M | -$86.19M | -$4.20 | -5.93% | -17.41% | N/A | N/A | |||
| ABBV | ABBVIE INC | $383.12B | $59.64B | $12.49B | $2.39B | $1.33 | 7.40% | 7.97% | -53.82% | -22.48% | |||
| GRFS | GRIFOLS SA | $5.93B | $8.01B | $1.71B | $174.36M | $0.26 | 2.57% | 5.57% | 258.21% | -25.16% | 2025-11-06 | ||
| JNJ | JOHNSON & JOHNSON | $448.13B | $92.15B | $39.78B | $25.12B | $10.43 | 5.08% | 2.65% | 72.97% | 10.06% | |||
| GILD | GILEAD SCIENCES INC | $152.10B | $28.86B | $10.97B | $6.31B | $5.05 | 3.81% | 5.41% | 494.12% | N/A | |||
| AZN | ASTRAZENECA PLC | $251.57B | $56.50B | $18.51B | $8.30B | $2.68 | 15.00% | 17.07% | 28.61% | 26.68% | 2025-11-06 | ||
| SNY | SANOFI | $123.79B | $50.74B | $18.05B | $10.74B | $4.34 | 18.08% | 3.68% | 139.57% | -2.50% | |||
| SCLX | SCILEX HOLDING CO | $128.47M | $44.24M | -$68.46M | -$122.99M | -$10.73 | -12.98% | N/A | N/A | N/A | |||
| MRK | MERCK & CO INC | $210.79B | $63.62B | $25.03B | $16.41B | $6.50 | 1.82% | 10.88% | 20.15% | 9.49% | |||
| NVS | NOVARTIS AG | $241.71B | $56.37B | $28.18B | $14.39B | $7.37 | 12.88% | 2.60% | -14.20% | 18.68% | |||
| AMGN | AMGEN INC | $172.24B | $35.97B | $16.53B | $7.01B | $13.03 | 10.56% | 7.56% | 65.15% | 0.85% | |||
| PFE | PFIZER INC | $139.93B | $62.79B | $15.84B | $9.83B | $1.72 | 3.89% | 14.38% | 126.32% | 4.35% | |||
| BIIB | BIOGEN INC | $22.51B | $10.07B | $2.71B | $1.61B | $10.99 | 4.77% | -6.73% | -1.08% | -18.34% | |||
| OGN | ORGANON & CO | $1.66B | $6.28B | $1.50B | $700.00M | $2.71 | -1.02% | N/A | -30.69% | N/A | |||
| MIRA | MIRA PHARMACEUTICALS INC | $29.18M | $0.00 | -$7.84M | -$7.77M | -$0.49 | N/A | N/A | N/A | N/A | 2025-12-03 | ||
| MDCX | MEDICUS PHARMA LTD | $40.98M | $0.00 | -$16.73M | -$16.51M | -$1.34 | N/A | N/A | N/A | N/A | 2025-11-21 | ||
| NSRX | NASUS PHARMA LTD | N/A | $0.00 | -$1.50M | -$1.53M | -$0.22 | N/A | N/A | N/A | N/A |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.